4-Methylmorpholine → 1-O-[(Z)-[amino-[(2S)-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-2-yl]methylidene]amino] 4-O-tert-butyl (2R)-2-(3-cyclohexylpropyl)butanedioate

HRID 1350243Notes

Reaction equation

HRID 1350243 reaction equation
[C:1]([O:5][C:6](=[O:21])[CH2:7][C@@H:8]([CH2:12][CH2:13][CH2:14][CH:15]1[CH2:20][CH2:19][CH2:18][CH2:17][CH2:16]1)[C:9]([OH:11])=[O:10])([CH3:4])([CH3:3])[CH3:2].C1C=CC2N(O)N=NC=2C=1.CN1CCOCC1.[NH2:39]/[C:40](=[N:54]\O)/[C@@H:41]1[CH2:46][CH2:45][CH2:44][CH2:43][N:42]1[C:47]([O:49][C:50]([CH3:53])([CH3:52])[CH3:51])=[O:48]>C(Cl)Cl.O>[NH2:54]/[C:40](=[N:39]\[O:10][C:9](=[O:11])[C@@H:8]([CH2:7][C:6]([O:5][C:1]([CH3:4])([CH3:2])[CH3:3])=[O:21])[CH2:12][CH2:13][CH2:14][CH:15]1[CH2:16][CH2:17][CH2:18][CH2:19][CH2:20]1)/[C@@H:41]1[CH2:46][CH2:45][CH2:44][CH2:43][N:42]1[C:47]([O:49][C:50]([CH3:52])([CH3:51])[CH3:53])=[O:48]

Participants

7

Procedure

A solution of (2R)-2-(2-tert-butoxy-2-oxoethyl)-5-cyclohexylpentanoic acid (preparation 168) (500 mg, 1.67 mmol) in DCM (20 ml) was treated with HOBt (227 mg, 1.67 mmol), NMM (203 μl, 1.85 mmol) and WSCDI (354 mg, 1.85 mmol) followed by tert-butyl(2S)-2-[(Z)-amino(hydroxyimino)methyl]-1-piperidinecarboxylate (WO 9945006) (406 mg, 1.67 mmol) and stirred at room temperature, under a nitrogen atmosphere for 18 hours. H2O (10 ml) was added and after 10 minutes the reaction mixture was separated in a 5 micron filter cartridge. The solvent was removed under reduced pressure to afford the title compound as a colourless foam.

Workup

  1. customwas separated in a 5 micron
  2. filtrationfilter cartridge
  3. customThe solvent was removed under reduced pressure

Sources & evidence

ORD record
ord-2b65ca12fe844578b4534be1f65e86a2
Source dataset
uspto-grants-2007_05
Patent number
US07214694B2

Reaction notes

Loading…